Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
AB InBev
BUD
$165B
| $4.55M | ﹤0.01% |
47,851
-3,111
| -6% | -$295K |
|
1927
Trupanion
TRUP
$1.18B
| $4.54M | ﹤0.01% |
178,793
+6,007
| +3% | +$176K |
|
1928
CALL
Clorox
CLX
$12.7B
| $4.54M | ﹤0.01% |
29,900
+7,000
| +31% | +$1.11M |
|
1929
iShares S&P 500 Value ETF
IVE
$49.8B
| $4.54M | ﹤0.01% |
38,106
+668
| +2% | +$78.4K |
|
|
HUYA
1930
Huya Inc
HUYA
$558M
| $4.53M | ﹤0.01% |
191,536
+140,336
| +274% | +$3.31M |
|
1931
Portland General Electric
POR
$5.77B
| $4.52M | ﹤0.01% |
80,277
+15,610
| +24% | +$869K |
|
1932
PUT
Illinois Tool Works
ITW
$84.5B
| $4.52M | ﹤0.01% |
28,900
-17,100
| -37% | -$2.6M |
|
1933
PUT
Intuit
INTU
$89B
| $4.52M | ﹤0.01% |
17,000
-227,200
| -93% | -$62.5M |
|
1934
CALL
Sanofi
SNY
$104B
| $4.52M | ﹤0.01% |
97,600
+20,700
| +27% | +$893K |
|
1935
CALL
Jacobs Solutions
J
$17B
| $4.52M | ﹤0.01% |
59,723
+13,782
| +30% | +$986K |
|
1936
Pinterest
PINS
$13.4B
| $4.52M | ﹤0.01% |
+170,865
| New | +$5.12M |
|
1937
KT
KT
$8.81B
| $4.52M | ﹤0.01% |
399,388
+271,831
| +213% | +$3.14M |
|
1938
Sonos
SONO
$1.85B
| $4.51M | ﹤0.01% |
336,165
+113,234
| +51% | +$1.42M |
|
|
CBD
1939
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $4.51M | ﹤0.01% |
234,308
+82,200
| +54% | +$1.84M |
|
1940
CALL
Yelp
YELP
$1.41B
| $4.5M | ﹤0.01% |
129,600
+21,100
| +19% | +$729K |
|
1941
Keurig Dr Pepper
KDP
$40.8B
| $4.5M | ﹤0.01% |
164,505
-83,342
| -34% | -$2.33M |
|
|
SKX
1942
PUT
DELISTED
Skechers
SKX
| $4.5M | ﹤0.01% |
120,400
-69,700
| -37% | -$2.39M |
|
1943
Equitable Holdings
EQH
$14.1B
| $4.5M | ﹤0.01% |
202,870
+109,245
| +117% | +$2.34M |
|
1944
Old National Bancorp
ONB
$10.2B
| $4.49M | ﹤0.01% |
260,765
-7,638
| -3% | -$130K |
|
1945
PUT
Bausch Health
BHC
$2.34B
| $4.48M | ﹤0.01% |
205,200
-22,000
| -10% | -$503K |
|
1946
CALL
YPF Sociedad Anonima American Depositary Shares (Each representing ten (10) Class D shares of Capital Stock)
YPF
$19.3B
| $4.48M | ﹤0.01% |
484,800
-38,400
| -7% | -$495K |
|
1947
Ciena
CIEN
$58.4B
| $4.48M | ﹤0.01% |
114,283
-542,326
| -83% | -$22.7M |
|
1948
Haemonetics
HAE
$4B
| $4.48M | ﹤0.01% |
35,530
-5,238
| -13% | -$665K |
|
1949
RPC Inc
RES
$1.3B
| $4.47M | ﹤0.01% |
797,270
+612,765
| +332% | +$3.64M |
|
|
NBIS
1950
Nebius Group N.V.
NBIS
$47.7B
| $4.47M | ﹤0.01% |
127,622
-92,489
| -42% | -$3.49M |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.